๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

High-Dose Medroxyprogesterone Acetate for the Treatment of Dysfunctional Uterine Bleeding in 24 Adolescents

โœ Scribed by M. Feridun Aksu; Riza Madazli; Erdal Budak; Ismail Cepni; AH Benian

Book ID
109056574
Publisher
Wiley (Blackwell Publishing)
Year
1997
Tongue
English
Weight
394 KB
Volume
37
Category
Article
ISSN
0004-8666

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacokinetic and pharmacodynamic basi
Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate
โœ Hans Christian Blossey; Hans Erik Wander; Johannes Koebberling; Professor Dr. Ge ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 728 KB

Postmenopausal patients with metastatic breast cancer were treated with medroxyprogesterone acetate (MPA) (Clinovir) in dosages between 500 and 1500 mg orally per day. The relation of MPA plasma concentrations and endocrine effects were studied in a longitudinal fashion. MPA exerted suppressive effe

Clinical trial of high-dose oral medroxy
Clinical trial of high-dose oral medroxyprogesterone acetate in the treatment of metastatic breast cancer and review of the literature
โœ Enrique Davila; Charles L. Vogel; Dawn East; Victoria Cairns; Susan Hilsenbeck ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 696 KB

Recent studies have suggested that there are benefits from the use of high-dose parenteral medroxyprogesterone acetate (MPA) in the treatment of metastatic breast cancer. The present study was designed to assess the efficacy and toxicity of high-dose oral MPA in women with clinical parameters sugges